Survival of patients with ovarian cancer in central and northern Denmark, 1998–2009

Figures & data

Table 1 Number of women with a first-time diagnosis of ovarian cancer in three age groups (1998–2009)

Age group	Year of diagnosis
	1998–2000	2001–2003	2004–2006	2007–2009
15–49 years	135 (20%)	134 (21%)	85 (14%)	64 (10%)
50–69 years	298 (45%)	304 (47%)	329 (53%)	310 (50%)
70+	231 (35%)	206 (32%)	203 (33%)	242 (39%)

Figure 1 Survival of ovarian cancer patients in four time periods.

Table 2 One-, 3-, and 5-year survival and MRRs, with the period 1998–2000 as a reference

	Year of diagnosis
	1998–2000	2001–2003	2004–2006	2007–2009
Number of cancer patients	664	644	617	616
Median age (years)	63	61	64	66
1 year
Survival	71% (68%–74%)	73% (70%–77%)	71% (67%–74%)	68% (64%–71%)
MRR	1 (reference)	0.92 (0.74–1.12)	1.04 (0.85–1.27)	1.15 (0.94–1.40)
MRRa	1 (reference)	0.95 (0.77–1.17)	1.04 (0.85–1.27)	1.05 (0.86–1.28)
3 year
Survival	48% (44%–51%)	50% (46%–53%)	50% (46%–54%)	46% (42%–50%)b
MRR	1 (reference)	0.95 (0.81–1.10)	0.95 (0.81–1.11)	1.05 (0.90–1.22)b
MRRa	1 (reference)	0.96 (0.83–1.12)	0.91 (0.78–1.06)	0.96 (0.83–1.12)b
5 year
Survival	40% (36%–44%)	40% (36%–44%)	41% (37%–44%)b	37% (34%–41%)b
MRR	1 (reference)	0.99 (0.86–1.13)	0.98 (0.85–1.13)b	1.07 (0.93–1.23)b
MRRa	1 (reference)	1.00 (0.87–1.15)	0.94 (0.82–1.08)b	0.99 (0.86–1.14)b

Notes: Estimates are presented with 95% confidence intervals;

a adjusted for age;

b predicted values.

Abbreviation: MRR, mortality rate ratio.

Table 3 One-, 3-, and 5-year cumulative survival for ovarian cancer patients in three different age groups

Age (years)	Year of diagnosis
	1998–2000	2001–2003	2004–2006	2007–2009
15–49
N umber of cancer patients	135	134	85	64
1-year survival	92% (86%–95%)	92% (86%–95%)	92% (84%–96%)	92% (82%–97%)
3-year survival	78% (70%–84%)	79% (71%–85%)	85% (75%–91%)	80% (69%–87%)a
5-year survival	71% (62%–78%)	71% (62%–78%)	72% (61%–80%)a	69% (57%–78%)a
50–69
N umber of cancer patients	298	304	329	310
1-year survival	79% (74%–83%)	79% (74%–83%)	78% (73%–82%)	79% (73%–83%)
3-year survival	52% (46%–58%)	51% (45%–56%)	53% (48%–59%)	52% (47%–58%)a
5-year survival	43% (37%–48%)	41% (36%–47%)	44% (38%–49%)a	43% (37%–48%)a
70+
N umber of cancer patients	231	206	203	242
1-year survival	49% (43%–56%)	53% (46%–60%)	50% (43%–57%)	48% (41%–54%)
3-year survival	24% (19%–30%)	28% (22%–34%)	30% (24%–36%)	28% (22%–34%)a
5-year survival	18% (13%–23%)	17% (12%–22%)	22% (17%–28%)a	20% (15%–26%)a

Notes: Estimates are presented with 95% confidence intervals in parentheses;

a predicted values.